We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Artivion Inc (AORT) Common Stock USD0.01

Sell:$28.50 Buy:$28.53 Change: $0.27 (0.95%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$28.50
Buy:$28.53
Change: $0.27 (0.95%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$28.50
Buy:$28.53
Change: $0.27 (0.95%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.

Contact details

Address:
1655 Roberts Boulevard N W
KENNESAW
30144
United States
Telephone:
+1 (770) 4193355
Website:
https://artivion.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AORT
ISIN:
US2289031005
Market cap:
$1.20 billion
Shares in issue:
41.92 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • James Mackin
    Chairman of the Board, President, Chief Executive Officer, Director
  • Lance Berry
    Chief Financial Officer, Executive Vice President - Finance
  • Jean Holloway
    Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
  • John Davis
    Senior Vice President - Global Sales and Marketing
  • Marshall Stanton
    Senior Vice President, Clinical Research and Chief Medical Officer
  • Amy Horton
    Chief Accounting Officer, Vice President
  • Florian Tyrs
    Vice President - Global Operations
  • Matthew Getz
    Vice President - Human Resources
  • Andrew Green
    Vice President - Regulatory Affairs
  • Rochelle Maney
    Vice President - Global Quality Assurance

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.